Clinical Psychopharmacology and Neuroscience indexed in CAS, DOI/Crossref, EMBASE, Korea Citation Index (KCI), KoreaMed, Korea Medical Citation Index (KoMCI), PubMed, PubMed Central (PMC), SCOPUS, SCI-expanded (SCIE), and Google Scholar:eISSN 2093-4327   pISSN 1738-1088

Cited by CrossRef (18)

  1. P. Barata, J.C. Melo, T. Maia. Tobacco smoking and psychotropic drugs. European Neuropsychopharmacology 2019;29:S471
    https://doi.org/10.1016/j.euroneuro.2018.11.704
  2. R. Icick, I. Melle, B. Etain, P.A. Ringen, S.R. Aminoff, M. Leboyer, M. Aas, C. Henry, T.D. Bjella, O.A. Andreassen, F. Bellivier, T.V. Lagerberg. Tobacco smoking and other substance use disorders associated with recurrent suicide attempts in bipolar disorder. Journal of Affective Disorders 2019;256:348
    https://doi.org/10.1016/j.jad.2019.05.075
  3. Kelly M Carpenter, Chelsea M Nash, Robert A Vargas-Belcher, Katrina A Vickerman, Vincent Haufle. Feasibility and Early Outcomes of a Tailored Quitline Protocol for Smokers With Mental Health Conditions. 2019;21:584
    https://doi.org/10.1093/ntr/ntz023
  4. Fernando Sarramea, María José Jaén-Moreno, Nuria Feu, Justa Redondo-Écija, Vicente Balanzá-Martínez, Luis Gutiérrez-Rojas, María Paz García-Portilla. Prepare the smoking cessation in severe mental illness: Early diagnosis and prevention opportunities. Revista de Psiquiatría y Salud Mental (English Edition) 2019;12:133
    https://doi.org/10.1016/j.rpsmen.2018.08.001
  5. Seetal Dodd, Lauren Arancini, Nieves Gómez-Coronado, Rudi Gasser, Dan I Lubman, Olivia M Dean, Michael Berk. Considerations when selecting pharmacotherapy for nicotine dependence. Expert Opinion on Pharmacotherapy 2019;20:245
    https://doi.org/10.1080/14656566.2018.1550072
  6. I. C. Passos, B. Mwangi, E. Vieta, M. Berk, F. Kapczinski. Areas of controversy in neuroprogression in bipolar disorder. Acta Psychiatr Scand 2016;134:91
    https://doi.org/10.1111/acps.12581
  7. Fernando Sarramea, María José Jaén-Moreno, Nuria Feu, Justa Redondo-Écija, Vicente Balanzá-Martínez, Luis Gutiérrez-Rojas, María Paz García-Portilla. Preparar la cesación tabáquica en el trastorno mental grave: diagnóstico precoz y oportunidades de prevención. Revista de Psiquiatría y Salud Mental 2019;12:133
    https://doi.org/10.1016/j.rpsm.2018.08.001
  8. Faith Dickerson, Maria B. Adamos, Emily Katsafanas, Sunil Khushalani, Andrea Origoni, Christina L.G. Savage, Jennifer Schroeder, Lucy A.B. Schweinfurth, Cassie Stallings, Kevin Sweeney, Robert Yolken. The association among smoking, HSV-1 exposure, and cognitive functioning in schizophrenia, bipolar disorder, and non-psychiatric controls. Schizophrenia Research 2016;176:566
    https://doi.org/10.1016/j.schres.2016.05.022
  9. John Lally, Abdullah Bin Sahl, Kieran C. Murphy, Fiona Gaughran, Brendon Stubbs. Serum Prolactin and Bone Mineral Density in Schizophrenia: A Systematic Review. Clin Psychopharmacol Neurosci 2019;17:333
    https://doi.org/10.9758/cpn.2019.17.3.333
  10. María José Jaén-Moreno, Nuria Feu, Justa Redondo-Écija, Francisco Javier Montiel, Cristina Gómez, Gloria I. del Pozo, Jose Ángel Alcalá, Luis Gutiérrez-Rojas, Vicente Balanzá-Martinez, Geli Marie Chauca, Laura Carrión, Maria Isabel Osuna, María Dolores Sánchez, Inmaculada Caro, Miriam Ayora, Francisca Valdivia, María Soledad López, Jose Manuel Poyato, Fernando Sarramea. Smoking cessation opportunities in severe mental illness (tobacco intensive motivational and estimate risk — TIMER—): study protocol for a randomized controlled trial. Trials 2019;20
    https://doi.org/10.1186/s13063-018-3139-9
  11. Ashely Collins, Oluwadamilare Ajayi, Savannah Diamond, William Diamond, Suzanne Holroyd. Tobacco Use and Associated Factors in Patients Presenting to a Psychiatric Emergency Room. Journal of Addiction 2018;2018:1
    https://doi.org/10.1155/2018/8102165
  12. R. Icick, S. Gard, M. Barde, M. Carminati, A. Desage, S. Guillaume, J. Scott, F. Bellivier. Physical and mental health burden in cases of bipolar disorder classified as current, former, or non-tobacco smokers. Journal of Affective Disorders 2017;208:406
    https://doi.org/10.1016/j.jad.2016.09.022
  13. Ching-Wen Chu, Chin-Han Kao, Chih-Kang Chan. Could the nicotine receptor partial agonist varenicline moderate manic symptoms in heavy smokers with manic episodes?. Aust N Z J Psychiatry 2018;52:205
    https://doi.org/10.1177/0004867417747403
  14. J. van Enkhuizen, J.W. Young. Negative Affective States and Cognitive Impairments in Nicotine Dependence. 2018.
    https://doi.org/10.1016/B978-0-12-802574-1.00002-8
  15. R. Icick, F. Vorspan, E. Karsinti, K. Ksouda, J-P. Lépine, G. Brousse, S. Mouly, F. Bellivier, V. Bloch. Gender-specific study of recurrent suicide attempts in outpatients with multiple substance use disorders. Journal of Affective Disorders 2018;241:546
    https://doi.org/10.1016/j.jad.2018.08.076
  16. Jentien M. Vermeulen, Robyn E. Wootton, Jorien L. Treur, Hannah M. Sallis, Hannah J. Jones, Stanley Zammit, Wim van den Brink, Guy M. Goodwin, Lieuwe de Haan, Marcus R. Munafò. Smoking and the risk for bipolar disorder: evidence from a bidirectional Mendelian randomisation study. Br J Psychiatry 2019:1
    https://doi.org/10.1192/bjp.2019.202
  17. Lina Martinsson, Jeanette Westman, Jonas Hällgren, Urban Ösby, Lena Backlund. Lithium treatment and cancer incidence in bipolar disorder. Bipolar Disord 2016;18:33
    https://doi.org/10.1111/bdi.12361
  18. Sarah Norman. PharmacotherapyFirst: A Multimedia Learning Resource. 2016.
    https://doi.org/10.21019/pharmacotherapyfirst.bipolar_overview